在denosumab (CARD) 研究后对alendronate和raloxifene进行比较:一项比较疗效试验
Sabashini K Ramchand1, Joy N Tsai2, Hang Lee3
1Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Harvard University, Boston, MA, USA. sramchand@mgh.harvard.edu.
概括
在服用德诺苏马布后,阿伦德罗纳酸有效地维持了骨矿物质密度 (BMD),并抑制了骨重塑标志物. 然而,拉洛西芬导致脊椎和部的BMD显著下降.
科学领域:
- 内分泌学 在内分泌学.
- 骨生物学 骨生物学 骨生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 停止服用德诺苏马布会导致快速的骨损失和骨折的风险.
- 双酸盐可以减轻这些影响,但缺乏比较试验.
- 替代性抗吸收药需要在denosumab治疗后进行评估.
研究的目的:
- 为了比较alendronate和raloxifene在denosumab后预防骨损失.
- 为了评估它们在管理高周转骨损失后的有效性.denosumab.
主要方法:
- 一个开放标签,随机对照试验,涉及51名绝经后妇女.
- 参与者接受了denosumab,随后接受了alendronate或raloxifene,持续了12个月.
- 骨重塑标志物和区域骨矿物质密度 (BMD) 被监测.
主要成果:
- 阿伦德罗纳特维持了德诺苏马布诱导的BMD增长,并抑制了骨周转.
- 拉洛西芬导致脊椎和整体部的骨质量显著下降.
- 在阿伦德罗纳酸和拉洛西芬组之间,骨质量变化有显著差异.
结论:
- 阿伦德罗纳酸比拉洛西芬更有效地维持了后denosumab的BMD.
- 相比于raloxifene,在denosumab治疗后,alendronate可以更好地保持骨重塑抑制.
更多相关视频
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
563
03:56Author Spotlight: Exploring the Impact of Lingnan Fire-Needle Therapy in Osteoporosis Intervention
Published on: April 26, 2024
653
相关概念视频
Osteoclasts in Bone Remodeling
3.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
543
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
543
Antihypertensive Drugs: Direct Renin Inhibitors
657
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
657
